Martha Akinbile, PMHNP-BC, FNP-C
NPI 1164943403 · Psychiatric/Mental Health Nurse Practitioner · Houston, TX
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1164943403
- Entity type
- Individual
- Primary specialty
- Psychiatric/Mental Health Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- PMHNP-BC, FNP-C
- Sex
- Female
- Sole proprietor
- No
- License
- 781497 (TX)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Nursing Service Providers
Physician Assistants & Advanced Practice Nursing Providers
Physician Assistants & Advanced Practice Nursing Providers
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
8 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Trazodone Hcl | 36 |
| Venlafaxine Hclbrand: Venlafaxine Hcl Er | 32 |
| Aripiprazole | 30 |
| Buspirone Hcl | 23 |
| Fluoxetine Hcl | 21 |
| Bupropion Hclbrand: Bupropion Xl | 18 |
| Escitalopram Oxalate | 17 |
| Mirtazapine | 16 |
| Bupropion Hcl |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$586 across 28 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2017-06-27
- Last updated
- 2023-05-11
- Certified
- 2023-05-11
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.